Abstract Breast cancer patients suffer impairment in cardiorespiratory fitness after treatment for primary disease, affecting patients' health and survival. The aim of this study was to evaluate the ability of a pragmatic exercise intervention to improve cardiorespiratory fitness of breast cancer patients after primary treatment. Between February 2013 and December 2014, 94 women with early stage (I-III) breast cancer, 1-36 months post-chemotherapy, and radiotherapy were randomly assigned to an intervention program (EX) combining supervised aerobic and resistance exercise (n = 44) or usual care (CON) (n = 45) for 12 weeks. Primary study endpoint was VO 2max . Secondary endpoints were muscle strength, shoulder range of motion, body composition, and quality of life (QoL). Assessments were undertaken at baseline, 12-week, and 6-month followups. Eighty-nine patients aged 29-69 years were assessed at baseline and 12 weeks. The EX group showed significant improvements in VO 2max , muscle strength, percent fat, and lean mass (p B 0.001 in all cases) and QoL compared with usual care (CON). Apart from body composition, improvements were maintained for the EX at 6-month follow-up. There were no adverse events during the testing or exercise intervention program. A combined exercise intervention produced considerable improvement in cardiorespiratory fitness, physical function, and quality of life in breast cancer patients previously treated with chemotherapy and radiation therapy. Importantly, most of these benefits were maintained 6 months after ceasing the supervised exercise intervention.
Introduction
Breast cancer is one of the most common cancers and a leading cause of cancer death in western women [1] . Fortunately, thanks to both mammogram screening campaigns and adjuvant therapies, breast cancer survival rates are increasing, and approximately, 80 % of patients remain cancer survivors at 5 years [2] .
However, breast cancer treatments have serious implications to health and quality of life [3] with high incidence of comorbidities following treatments [4] . In addition, breast cancer patients show lower levels of physical capacity and mobility compared to women without cancer of similar age [5] . These impairments to physical capacity, assessed by maximum oxygen consumption (VO 2max ) [6] , and changes in body composition (muscle mass loss and fat mass gain) have been related to poorer survival and higher risk of metabolic diseases [7] . It has been reported that exercise is an integrative intervention that could eliminate, prevent, or reduce these side effects [8] . However, very few patients are aware of and follow the exercise recommendations [9, 10] possibly because clinical oncologists, during early treatment of breast cancer, may not place emphasis on exercise with this therapy being relegated to a low priority in the (neo) adjuvant treatments. Further, access and pragmatic implementation of exercise for this patient group may be difficult depending on available facilities and expertise. Finally, the persistence of benefits of exercise interventions in cancer survivors has been questioned [11] necessitating trials with longer term follow-up.
Therefore, the purpose of this study was to examine the effects of a combined exercise program highly transferable into best practice supportive care, incorporating aerobic and resistance exercises, on physical capacity of women with breast cancer following curative treatments and to evaluate the maintenance of any benefits at 6-month follow-up.
We hypothesized that a specific exercise intervention could restore physical capacity of breast cancer patients who have recently finished adjuvant chemotherapy and radiotherapy. We designed a randomized controlled trial to examine the effects of a combined exercise program on the physical capacity of these patients.
Materials and methods
This was a prospective randomized controlled trial (RCT) with participants randomly allocated in a 1:1 ratio to one of two study arms: supervised exercise plus dietary counseling (EX) or non-intervention control group (CON). Eligible patients that signed informed consent were randomly allocated to EX or CON groups by means of a random number table by an external person not involved in testing or training the participants [12] . The study was developed by collaboration between different institutions (Universidad Politécnica de Madrid (UPM), Spanish Group of Cancer Patients (GEPAC), Hospital General Universitario Gregorio Marañón, Hospital Universitario Puerta de Hierro-Majadahonda, and Hospital Madrid Norte-Sanchinarro). The intervention was carried out at facilities of the Physical and Sport Science Institute-INEF (INEF), and the study was approved by the Human Ethics Committee of UPM. Prior to any exercise testing or training, each participant's general health and readiness were evaluated using the PAR-Q [13] .
GEPAC staff and medical oncologists from the 4 different institutions undertook patient identification and recruitment. Inclusion criteria were (1) previously confirmed diagnosis of stage I to III breast cancer; (2) age between 18 and 70 years; (3) at least 1 month and at most 3 years from completion of radiotherapy and chemotherapy, although they could have been under hormonal or biological treatments; (4) oncologist approval; and (5) willing to participate and sign the informed consent. Exclusion criteria were any other illness or disability incompatible with exercise (e.g., cardiac condition, uncontrolled hypertension, severe pulmonary disease, mental illness, or anticoagulant treatments).
Intervention group
The exercise program was designed and supervised by an oncologic exercise specialist based on the ACSM guidelines [14] . The exercise program consisted of twice-weekly supervised exercise sessions combining aerobic and resistance exercise that was increased in intensity over 12 weeks in a familiar and trusted environment, which promoted socialization between participants. Program characteristics are presented in Table 1 . The intervention was developed as a pragmatic, nonclinical intervention, implemented with minimal cost and equipment increasing the transferability into the clinical environment. It was also complemented with an education program about exercise and nutrition guidelines. An initial orientation session on exercise was conducted outlining current exercise recommendations and the importance of adopting lifestyle changes to improve outcomes for breast cancer survivors.
The nutrition program consisted of three workshops, where specific concepts of nutrition and diet were explained. The first class was on the topic of different groups of nutrients. The second class was a practical session about interpreting food labels and relating measurements of food portions with recommendations for a healthy diet. The final session addressed the ten best (i.e., rich in antioxidants) and the ten worst (i.e., rich in animal fat) dietary components, which might prevent or promote cancer. The study dieticians 'recommended patients try to adopt the Mediterranean diet [15] .
Non-intervention group
CON participants were asked to maintain their usual behavior, without changes in their physical activity levels or diet. At the end of the twelve weeks, patients in the CON group were offered to participate in the exercise classes for ethical considerations and to reduce attrition and contamination.
Study endpoints
All clinical and patient-reported outcomes were assessed at baseline and 12 weeks. EX participants were also assessed 6 months following completion of the 12-week supervised intervention to determine if benefits were maintained.
Demographic and descriptive data
Age, marital status, profession, subtype of tumor, type of resection, lymph node resection, type of endocrine medication, menopausal status, and physical activity level (sedentary, defined as less than 30 min of activity per week; low defined as between 30 and 150 min of activity per week; moderate defined as between 150 and 300 min of activity per week; or high defined as over 300 min of activity per week) [14] were recorded using questionnaires. Patients were asked not to include the exercise intervention time in the questionnaires at final assessments to be able to compare these assessments with the baseline and the follow-up measurements or changes in habitual physical activity.
Primary outcome: cardiorespiratory capacity
Cardiorespiratory capacity was assessed by estimating the VO 2max of each individual at each test occasion [16] . Each participant completed a submaximal test using the modified Bruce protocol performed on a treadmill (PANATA, Italy) at 85 % of heart rate-reserve (HRR). The Canadian Society for Exercise Physiology Equation Can [16] was then applied to predict VO 2max .
Secondary outcomes
Muscle strength and shoulder range of motion Isometric muscle strength was assessed using isometric dynamometers for hand-grip (TKK 5401, Grip-D, Japan) and legs and back (TKK 5402, Grip-D, Japan) strength. The Strength Index was obtained by adding all isometric strength values and dividing the result by the participant's body weight [17] .
Dynamic muscle strength was assessed using the 8-repetition maximum (RM) test protocol for chest press and leg extension exercises with subsequent prediction of 1-RM strength following the National Strength and Conditioning Association guidelines [14] and Mayhew formulae [18] . Muscular endurance was determined as maximal number of repetitions performed at 50 % of 1RM for the chest press and 70 % of 1RM for the leg extension. All strength and endurance tests were performed using pinloaded resistance machines (PANATA, Italy).
Body composition and anthropometrics Body fat and lean mass percentage were assessed by electrical bioimpedance (BC-601F, Tanita, Japan) [19] . Anthropometric assessments included weight, height, body mass index (BMI), waist and hip circumferences, and waist-hip ratio [17] . Arm circumferences were measured in both limbs every 10 cm from the metacarpal-phalangeal joints to 15 cm proximal to the lateral epicondyles to assess arm volume and potential lymphedema [20, 21] .
Quality of life (QoL) QoL was assessed using the SF-36 questionnaire which consists of 36 items divided into eight dimensions that have been interpreted together and separately with higher scores on this scale indicating higher levels of health [22, 23] . The eight subdomains include physical functioning, role limitation due to physical health, bodily pain, general health perception, vitality, social functioning, role limitation due to emotional health and mental health.
Statistical analysis
Based on the previous work by Jones et al. [6] , a difference in VO 2max change of 0.306 (ml/kg*min) between the two groups is considered clinically relevant and used to estimate the required sample size. Using an alpha level of 0.05, a final sample size of 86 patients was required to obtain a statistical power of 80 %. Allowing for 10 % attrition, the target recruitment was set at 95 patients. Data were analyzed using SPSS Version 20.0 (IBM, New York). Confidence interval was set at 95 %, and criteria for significance at p B 0.05 and tailed comparison to determine significance of the results. Continuous data are presented as mean ± standard deviation (mean ± SD) and categorical data as frequencies and percentages in the tables. Significant differences are presented as standardized mean difference (SMD), confidence interval of the difference (CI), and p value (SMD; 95 % CI; p). Groups were compared in terms of demographic variables by Chisquared analysis, if they were categorical, and by ANOVA if they were continuous. For the other measures, ANCOVA adjusted for age and baseline values was used to analyse continuous data and Chi Square for nominal data. ANOVA was used to compare the 6-month follow-up assessments for EX participants.
Results
Two hundred and thirty-five women were screened and 94 were enrolled. Women were recruited from February 2013 to December 2014 and randomly assigned to the two study arms (Fig. 1) . No differences in baseline measures were found between groups, except for age (Table 2) .
Eighty-nine women (n = 47 in EX group and n = 47 in CON group, respectively) completed all of the testing protocol baseline and 12 weeks (Table 3 ) and 36 women from the EX group completed measurements at 6 months follow-up (Table 4) .
Adherence and level of physical activity
The adherence to the program was 87.7 % defined as the percentage of patients that finally ending the whole program, and 86 % of the EX participants returned to perform the follow-up assessments at 6 months. Participant attendance for the exercise and diet sessions was over 80 % with 82 % attending all scheduled sessions. With respect to the number of minutes of physical activity performed per week, there were significant differences between groups (v 2 = 30.78; p \ 0.001). At baseline, only 36 % of women in both groups were meeting the recommended 150 min of physical activity per week as per ASCM guidelines. Following 12 weeks, 91 % of women in EX and only 49 % in CON were meeting these guidelines (p = 0.001). At 6-month follow-up, 79 % of women in EX were still meeting the guidelines.
Primary outcome: cardiorespiratory capacity
Following the intervention, VO 2max was significantly higher for EX compared to CON (p \ 0.001). Changes in VO 2max in both groups are presented in Fig. 2 . At 6-month follow-up, EX maintained their VO 2max showing no significant decline.
Secondary outcomes
Muscle strength and shoulder range of motion Isometric strength index increased significantly in women allocated to EX compared with those allocated to CON (p = 0.004). Further, EX improved maximal strength significantly more than CON for chest press (p \ 0.001) and leg extension (p = 0.001). These differences were also significant when expressed relative to body weight in both the chest press (p \ 0.001) and leg extension (p \ 0.001).
Muscle endurance was significantly lower in CON than EX participants for the chest press (p \ 0.001) and leg extension (p \ 0.001) at 12 weeks. At 6 months follow-up EX maintained or improved both (Table 4) .
Body composition
EX showed significant reductions in fat mass percentage (p \ 0.001) and significant increases in lean body mass (p = 0.001). These changes in body composition were not maintained by EX during the subsequent 6 months, presenting a significant rise in fat mass (p = 0.001) and a reduction in lean mass (p = 0.74). No differences between groups in affected arm volume were observed (p [ 0.05) (results not presented).
Quality of life
EX participants showed significantly higher SF36 scores in mental and physical dimensions (p = 0.002; p = 0.001, respectively) and significant improvements in all SF36 subdomains, compared with CON, except for the role limitation due to emotional health. These changes were maintained for the EX group at 6-month follow-up.
Discussion
There can be no contention that appropriate exercise is of physiological, psychological, and survival benefit for breast cancer patients. However, pragmatic implementation of exercise into patient support and the longer-term benefits are much less understood. We found that a low-cost and specific intervention of combined exercise and dietary counseling can improve the cardiorespiratory performance of breast cancer patients, as shown by significant increase in VO 2max capacity. We also examined the effects of the intervention on muscle strength, body composition, and quality of life with similar beneficial outcomes.
Previous reviews, including meta-analysis, have reported results in accord to our VO 2max improvements [6, 24] . VO 2max has been established as an important predictor of anthracycline and trastuzumab-induced left ventricular dysfunction [25, 26] , and improvement in VO 2max capacity has been related to reductions in all cause of mortality and cancer specific mortality [27, 28] . However, this study has some different and noteworthy points compared with previous research. First and foremost, our study was developed and designed as an easy to follow and a low-cost intervention, which translated into high adherence and attendance. Second, the proposed intervention used in our study is highly transferable to pragmatic implementation in clinical settings due to the capacity to personalize exercise sessions and activities, something that has been observed as an important factor to increase exercise adherence [11, 29] . Other previous studies have carried out controlled intervention developed in lab conditions, which are usually planed as one to one and low motivation activities [30] . These interventions look for high-quality data but are not transferable and reproducible in clinical environment. However, our intervention shows that variables can be controlled using a motivating methodology based on the participant necessities [11] , mixing resistance, and endurance activities with low-cost material and creating a transferable and reproducible methodology in the hospitals and medical centers. Of high importance, at 6-month follow-up, approximately 80 % of patients were still performing 150 min of moderate exercise per week, which meets the ACSM recommendation at least for aerobic exercise. This can be considered as an effective change in patients lifestyle, which should provide longer-term health benefit.
Muscle strength was also significantly increased as a result of the intervention, particularly maximal strength of the chest muscles that are usually affected by local treatments [31] . Improving or preserving muscle strength is important because of increased resilience to musculoskeletal injury and muscular strength, playing a fundamental role in reducing joint pain and physical limitation, thus increasing QoL [32, 33] . These results are complemented with a significant improvement in affected shoulder range of motion. It is estimated that around 60 % of patients present one upper-body symptom, which affects breast cancer patients' daily activities and reduces significantly their quality of life [31] . Others have previously shown similar results to ours [34] [35] [36] [37] [38] [39] [40] , despite the fact that most of these studies involved longer interventions. We are encouraged that shorter interventions of even 12 weeks appear effective to reduce such treatment side effects achieving similar improvements.
We also found a significant reduction in body fat mass percentage and increase in lean mass, changing body composition toward a more healthy balance, despite the fact that body weight and BMI did not change significantly. These are important findings as higher levels of fat mass and lower levels of muscle mass have been related to poorer survival [41, 42] and high risk of metabolic diseases [42] [43] [44] indicating the need to restore body composition of breast cancer survivors after treatments. Previous reviews have indicated that it is insufficient evidence for the effect of exercise on body composition in cancer patients [14, 45] , but the few studies addressing this topic have found similar results to ours, suggesting that exercise may be an efficient tool to restore energy balance and thus improve body composition [43, 46] . The positive changes in body composition seen in our study after the 12-week intervention program suggests that such a program could be of great interest if introduced as a critical component of patient management, in concordance with the findings of other studies.
As has been reported in several previous studies [34, 47, 48] , women in the exercise group did not present significant swelling in the affected arm, further demonstrating that combined exercise interventions do not increase the risk of developing or exacerbating lymphedema [49, 50] . It is hoped that this growing research evidence finally dismisses reticence to prescribe resistance training for patients with lymphoedema.
Apart from improvements in objectively measured outcomes of physical capacity, the exercise group also showed significant changes in all subdomains of the SF-36 and in Table 3 Comparison between groups for study outcomes at baseline and 12 weeks presented as mean ± SD, standardized mean difference (SMD; 95 % CI; p), 
\0.001
Maximal strength legs/weight general QoL compared with usual care, demonstrating the potential of this intervention to improve patient-reported outcomes (PROs). Our results are similar to previous studies and meta-analysis [8, 36, [51] [52] [53] [54] [55] [56] . However, this is a post-treatment study, which may lead to greater changes than previous studies developed during chemotherapy [57] , suggesting that the best opportunity to modify PROs should be after cancer (neo) adjuvant treatments. With regard to longer-term maintenance of adaptations and benefit, EX retained the improvements in VO 2max and significantly improved muscle strength at 6-month followup. However, body fat mass percentage and lean mass returned to baseline, which suggests that high levels of physical activity or high intensity exercise may be necessary to maintain body composition improvements. Only a small number of studies have followed up exercise intervention achievements in cancer patients [11] , suggesting that more follow-up studies are needed to design effective interventions to restore physical status of breast cancer survivors after treatments. In addition, changes in QoL were maintained after 6-month follow-up, which suggest that an integrative intervention could be effective to reduce physical and psychological side effects in a lasting way.
This study had some limitations, and the results have to be interpreted in this light. Our integrative program included not only an exercise program but nutritional recommendations as well. The impact of the dietary recommendations on the variables measured in our study cannot be established and separated from the benefits provided by the exercise program. However, a previous review has suggested that dietary intervention is insufficient to restore body composition [58] . It is unlikely, then that the dietary recommendations by themselves could have played a major role in the observed changes. In addition, self-reported assessments of questionnaires are normally inferior to objective measures. However, the used questionnaires have been extensively validated. Regarding the long-term maintenance of the benefit, our study follows patients only for 6 months. Additional studies with longer follow-up are necessary to establish the maintenance of benefit over multiple years. Lastly, our patients were well-functioning individuals mostly motivated to undertake the training program and may not be representative of all breast cancer patients recently completing adjuvant chemotherapy and radiotherapy.
Among the strengths of our study, we can mention the relatively large proportion of patients retained at 12 week and 6 month assessments, the high compliance to the intervention, and a very pragmatic, integrative group-based intervention that was implemented. Further, to our knowledge, this is the largest exercise intervention in breast cancer patients ever conducted in Spain.
In conclusion, we report that a combined aerobic and resistance exercise intervention results in statistically and clinically significant improvement in VO 2max in breast cancer survivors, as well as improvements in muscle strength, body composition, quality of life, and fatigue. Much of this benefit is retained at 6 month post-intervention. Future studies are needed to establish the ability of this integrative intervention to maintain the benefits beyond 6 months. 
